Kevin Bowman

2.2k total citations
17 papers, 825 citations indexed

About

Kevin Bowman is a scholar working on Biological Psychiatry, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Kevin Bowman has authored 17 papers receiving a total of 825 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Biological Psychiatry, 5 papers in Molecular Biology and 5 papers in Psychiatry and Mental health. Recurrent topics in Kevin Bowman's work include Tryptophan and brain disorders (6 papers), Stress Responses and Cortisol (3 papers) and Economic Growth and Productivity (3 papers). Kevin Bowman is often cited by papers focused on Tryptophan and brain disorders (6 papers), Stress Responses and Cortisol (3 papers) and Economic Growth and Productivity (3 papers). Kevin Bowman collaborates with scholars based in United States and China. Kevin Bowman's co-authors include Peggy Scherle, Lance Leopold, Holly K. Koblish, Andrew P. Combs, Jordan S. Fridman, Jack Shi, Robert Newton, Richard Schaub, Timothy C. Burn and Thomas F. Gajewski and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Kevin Bowman

14 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin Bowman United States 8 430 262 205 200 198 17 825
Erika Sutanto‐Ward United States 14 876 2.0× 544 2.1× 597 2.9× 414 2.1× 282 1.4× 22 1.6k
Galina Gritsina United States 13 216 0.5× 273 1.0× 276 1.3× 297 1.5× 72 0.4× 17 831
Péter Ugocsai Germany 15 64 0.1× 246 0.9× 112 0.5× 93 0.5× 14 0.1× 23 558
Judit Dobos Hungary 18 42 0.1× 443 1.7× 192 0.9× 377 1.9× 32 0.2× 33 989
Quang T. Luong United States 11 36 0.1× 419 1.6× 59 0.3× 168 0.8× 46 0.2× 16 754
L. J. Brandes Canada 12 34 0.1× 269 1.0× 193 0.9× 120 0.6× 88 0.4× 24 623
Ashley Parks United States 6 85 0.2× 144 0.5× 91 0.4× 69 0.3× 37 0.2× 7 370
Ahmed Sadik Germany 9 125 0.3× 211 0.8× 116 0.6× 73 0.4× 47 0.2× 11 420
R.Patricia Bogdanovic Canada 8 36 0.1× 178 0.7× 109 0.5× 79 0.4× 88 0.4× 9 449
Sara Gagno Italy 14 28 0.1× 153 0.6× 79 0.4× 240 1.2× 8 0.0× 42 548

Countries citing papers authored by Kevin Bowman

Since Specialization
Citations

This map shows the geographic impact of Kevin Bowman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Bowman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Bowman more than expected).

Fields of papers citing papers by Kevin Bowman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Bowman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Bowman. The network helps show where Kevin Bowman may publish in the future.

Co-authorship network of co-authors of Kevin Bowman

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Bowman. A scholar is included among the top collaborators of Kevin Bowman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Bowman. Kevin Bowman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Patel, Hitisha, et al.. (2025). Abstract 5612: Taletrectinib, a next generation selective ROS1 inhibitor, inhibits growth of ROS1 wild-type and ROS1-G2032R xenografts. Cancer Research. 85(8_Supplement_1). 5612–5612. 1 indexed citations
2.
Chen, Yaoyu, Matthew C. Stubbs, Xiaoming Wen, et al.. (2020). Characterization of INCB00928, a Potent and Selective ALK2 Inhibitor for the Treatment of Anemia. Blood. 136(Supplement 1). 52–52. 9 indexed citations
3.
Zhang, Yan, Kevin Bowman, Janet Maleski, Sharon Diamond, & Swamy Yeleswaram. (2019). Short Communication: Effects of Epacadostat on Brain Extracellular Fluid Concentrations of Serotonin—an Intracerebral Microdialysis Study in Sprague-Dawley Rats. Drug Metabolism and Disposition. 47(7). 710–714.
4.
Beatty, Gregory L., Peter J. O’Dwyer, Jason Clark, et al.. (2017). First-in-Human Phase I Study of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in Patients with Advanced Solid Malignancies. Clinical Cancer Research. 23(13). 3269–3276. 240 indexed citations
5.
Shi, Jack, Kevin Bowman, Xuejun Chen, et al.. (2016). Population Pharmacokinetic and Pharmacodynamic Modeling of Epacadostat in Patients With Advanced Solid Malignancies. The Journal of Clinical Pharmacology. 57(6). 720–729. 13 indexed citations
6.
Koblish, Holly K., Niu Shin, Leslie Hall, et al.. (2015). Abstract 5416: Activity of the pan-PIM kinase inhibitor INCB053914 in models of acute myelogenous leukemia. Cancer Research. 75(15_Supplement). 5416–5416. 2 indexed citations
7.
Newton, Robert, Peggy Scherle, Kevin Bowman, et al.. (2012). Pharmacodynamic assessment of INCB024360, an inhibitor of indoleamine 2,3-dioxygenase 1 (IDO1), in advanced cancer patients.. Journal of Clinical Oncology. 30(15_suppl). 2500–2500. 22 indexed citations
8.
Bowman, Kevin, et al.. (2012). Invention, Innovation, and Wage Inequality in Developed Countries. Eastern Economic Journal. 39(4). 511–529.
9.
Shin, Niu, Maryanne Covington, Di Bian, et al.. (2011). INCB38579 is a novel, potent and selective histamine H4 receptor antagonist with activity in rodent models of inflammatory pain (117.28). The Journal of Immunology. 186(1_Supplement). 117.28–117.28. 1 indexed citations
10.
Koblish, Holly K., Michael Hansbury, Kevin Bowman, et al.. (2010). Hydroxyamidine Inhibitors of Indoleamine-2,3-dioxygenase Potently Suppress Systemic Tryptophan Catabolism and the Growth of IDO-Expressing Tumors. Molecular Cancer Therapeutics. 9(2). 489–498. 204 indexed citations
11.
Bowman, Kevin. (2009). Holarchical Development: Discovering and Applying Missing Drives from Ken Wilber’s Twenty Tenets. International Journal of Transpersonal Studies. 28(1). 1–24. 2 indexed citations
12.
Yue, Eddy W., Brent Douty, Brian Wayland, et al.. (2009). Discovery of Potent Competitive Inhibitors of Indoleamine 2,3-Dioxygenase with in Vivo Pharmacodynamic Activity and Efficacy in a Mouse Melanoma Model. Journal of Medicinal Chemistry. 52(23). 7364–7367. 187 indexed citations
13.
Bowman, Kevin. (2008). ENDOGENOUS HUMAN CAPITAL INVESTMENT AND THE INTERACTION OF FRONTIER AND ADOPTIVE KNOWLEDGE ON GROWTH AND WAGE INEQUALITY. Economics of Innovation and New Technology. 17(6). 571–592. 1 indexed citations
14.
Bowman, Kevin. (2007). Knowledge stocks by distance to frontier: Linking low education inequality to high growth in developing countries. Journal of Asian Economics. 18(4). 613–635. 7 indexed citations
15.
16.
17.
Huisman, T. H. J., et al.. (1974). Microchromatography of hemoglobins. II. A rapid method for the determination of hemoglobin A2.. PubMed. 83(4). 657–64. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erika Sutanto‐Ward Breakdown of academic impact, for papers by Galina Gritsina Breakdown of academic impact, for papers by Péter Ugocsai Breakdown of academic impact, for papers by Judit Dobos Breakdown of academic impact, for papers by Quang T. Luong Breakdown of academic impact, for papers by L. J. Brandes Breakdown of academic impact, for papers by Ashley Parks Breakdown of academic impact, for papers by Ahmed Sadik Breakdown of academic impact, for papers by R.Patricia Bogdanovic Breakdown of academic impact, for papers by Sara Gagno
Rankless by CCL
2026